Literature DB >> 16514135

Chronic inflammation: a common and important factor in the pathogenesis of neoplasia.

David Schottenfeld1, Jennifer Beebe-Dimmer.   

Abstract

A causal link between chronic inflammation and carcinogenesis is explored by reviewing illustrative examples of specific cancers and causal agents and mechanisms. The causal agents or pathologic conditions include microbial agents, gastroesophageal reflux, chronic cholecystitis and cholelithiasis, inflammatory bowel disease, and specific agents that cause chronic obstructive or diffuse interstitial lung disease. The proportion of total cancer deaths attributable to infectious agents is estimated to be about 20% to 25% in developing countries and 7% to 10% in more industrialized countries. Recurrent or persistent inflammation may induce, promote, or influence susceptibility to carcinogenesis by causing DNA damage, inciting tissue reparative proliferation, and/or creating a stromal "soil" that is enriched with cytokines and growth factors. Future research on the complex cascade of cellular and humoral factors participating in the chronic inflammatory process will further understanding of the pathogenesis of various cancers and potentially provide a rationale for targeted chemopreventive interventions.

Entities:  

Mesh:

Year:  2006        PMID: 16514135     DOI: 10.3322/canjclin.56.2.69

Source DB:  PubMed          Journal:  CA Cancer J Clin        ISSN: 0007-9235            Impact factor:   508.702


  154 in total

Review 1.  [Pathological anatomical characteristics of Klatskin tumors. Classification, current molecular biological aspects, prognosis factors].

Authors:  J Munding; A Tannapfel
Journal:  Chirurg       Date:  2012-03       Impact factor: 0.955

2.  Opposing effects of bortezomib-induced nuclear factor-κB inhibition on chemical lung carcinogenesis.

Authors:  Sophia P Karabela; Ioannis Psallidas; Taylor P Sherrill; Chrysoula A Kairi; Rinat Zaynagetdinov; Dong-Sheng Cheng; Spyridoula Vassiliou; Frank McMahon; Linda A Gleaves; Wei Han; Ioannis Stathopoulos; Spyros G Zakynthinos; Fiona E Yull; Charis Roussos; Ioannis Kalomenidis; Timothy S Blackwell; Georgios T Stathopoulos
Journal:  Carcinogenesis       Date:  2012-01-27       Impact factor: 4.944

3.  Nedd4L modulates the transcription of metalloproteinase-1 and -13 genes to increase the invasive activity of gallbladder cancer.

Authors:  Tamotsu Takeuchi; Yoshihiro Adachi; Tomoko Nagayama; Mutsuo Furihata
Journal:  Int J Exp Pathol       Date:  2010-10-05       Impact factor: 1.925

4.  Use of glucosamine and chondroitin supplements in relation to risk of colorectal cancer: Results from the Nurses' Health Study and Health Professionals follow-up study.

Authors:  Elizabeth D Kantor; Xuehong Zhang; Kana Wu; Lisa B Signorello; Andrew T Chan; Charles S Fuchs; Edward L Giovannucci
Journal:  Int J Cancer       Date:  2016-07-18       Impact factor: 7.396

5.  Association of haplotypes of inflammation-related genes with gastric preneoplastic lesions in African Americans and Caucasians.

Authors:  Jovanny Zabaleta; Maria C Camargo; Marylyn D Ritchie; Maria B Piazuelo; Rosa A Sierra; Stephen D Turner; Alberto Delgado; Elizabeth T H Fontham; Barbara G Schneider; Pelayo Correa; Augusto C Ochoa
Journal:  Int J Cancer       Date:  2011-02-01       Impact factor: 7.396

6.  C-reactive protein and risk of colorectal adenoma according to celecoxib treatment.

Authors:  Andrew T Chan; Camelia S Sima; Ann G Zauber; Paul M Ridker; Ernest T Hawk; Monica M Bertagnolli
Journal:  Cancer Prev Res (Phila)       Date:  2011-08

Review 7.  Nrf2-Keap1 signaling as a potential target for chemoprevention of inflammation-associated carcinogenesis.

Authors:  Joydeb Kumar Kundu; Young-Joon Surh
Journal:  Pharm Res       Date:  2010-03-31       Impact factor: 4.200

8.  Polymorphisms in innate immunity genes and lung cancer risk in Xuanwei, China.

Authors:  Min Shen; Roel Vermeulen; Preetha Rajaraman; Idan Menashe; Xingzhou He; Robert S Chapman; Meredith Yeager; Gilles Thomas; Laurie Burdett; Amy Hutchinson; Jeff Yuenger; Stephen Chanock; Qing Lan
Journal:  Environ Mol Mutagen       Date:  2009-05       Impact factor: 3.216

9.  Inhibition of phorbol ester-induced mouse skin tumor promotion and COX-2 expression by celecoxib: C/EBP as a potential molecular target.

Authors:  Kyung-Soo Chun; Joydeb Kumar Kundu; Kwang-Kyun Park; Won-Yoon Chung; Young-Joon Surh
Journal:  Cancer Res Treat       Date:  2006-06-30       Impact factor: 4.679

10.  Use of glucosamine and chondroitin supplements and risk of colorectal cancer.

Authors:  E D Kantor; J W Lampe; U Peters; D D Shen; T L Vaughan; E White
Journal:  Cancer Causes Control       Date:  2013-03-26       Impact factor: 2.506

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.